These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 37468900)

  • 1. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease.
    Boeddrich A; Haenig C; Neuendorf N; Blanc E; Ivanov A; Kirchner M; Schleumann P; Bayraktaroğlu I; Richter M; Molenda CM; Sporbert A; Zenkner M; Schnoegl S; Suenkel C; Schneider LS; Rybak-Wolf A; Kochnowsky B; Byrne LM; Wild EJ; Nielsen JE; Dittmar G; Peters O; Beule D; Wanker EE
    Genome Med; 2023 Jul; 15(1):50. PubMed ID: 37468900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep proteome profiling of the hippocampus in the 5XFAD mouse model reveals biological process alterations and a novel biomarker of Alzheimer's disease.
    Kim DK; Han D; Park J; Choi H; Park JC; Cha MY; Woo J; Byun MS; Lee DY; Kim Y; Mook-Jung I
    Exp Mol Med; 2019 Nov; 51(11):1-17. PubMed ID: 31727875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins.
    Rangaraju S; Dammer EB; Raza SA; Gao T; Xiao H; Betarbet R; Duong DM; Webster JA; Hales CM; Lah JJ; Levey AI; Seyfried NT
    Mol Neurodegener; 2018 Jun; 13(1):34. PubMed ID: 29954413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal and Sex-Linked Protein Expression Dynamics in a Familial Model of Alzheimer's Disease.
    Blasco Tavares Pereira Lopes F; Schlatzer D; Wang R; Li X; Feng E; Koyutürk M; Qi X; Chance MR
    Mol Cell Proteomics; 2022 Sep; 21(9):100280. PubMed ID: 35944844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease.
    Wang H; Dey KK; Chen PC; Li Y; Niu M; Cho JH; Wang X; Bai B; Jiao Y; Chepyala SR; Haroutunian V; Zhang B; Beach TG; Peng J
    Mol Neurodegener; 2020 Jul; 15(1):43. PubMed ID: 32711556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [
    Sandhu YK; Bath HS; Shergill J; Liang C; Syed AU; Ngo A; Karim F; Serrano GE; Beach TG; Mukherjee J
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Dynamics of β-Amyloid Proteoforms Accumulation in the Brain of a 5xFAD Mouse Model of Alzheimer's Disease.
    Bugrova AE; Strelnikova PA; Indeykina MI; Kononikhin AS; Zakharova NV; Brzhozovskiy AG; Barykin EP; Pekov SI; Gavrish MS; Babaev AA; Kosyreva AM; Morozova AY; Degterev DA; Mitkevich VA; Popov IA; Makarov AA; Nikolaev EN
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraneuronal Aβ detection in 5xFAD mice by a new Aβ-specific antibody.
    Youmans KL; Tai LM; Kanekiyo T; Stine WB; Michon SC; Nwabuisi-Heath E; Manelli AM; Fu Y; Riordan S; Eimer WA; Binder L; Bu G; Yu C; Hartley DM; LaDu MJ
    Mol Neurodegener; 2012 Mar; 7():8. PubMed ID: 22423893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease.
    Yang Y; García-Cruzado M; Zeng H; Camprubí-Ferrer L; Bahatyrevich-Kharitonik B; Bachiller S; Deierborg T
    Brain Behav Immun; 2023 Oct; 113():228-247. PubMed ID: 37437821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of alzheimer's disease.
    Govindarajan K; Kar S
    J Nanobiotechnology; 2023 Jul; 21(1):216. PubMed ID: 37424018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level.
    Sadleir KR; Eimer WA; Cole SL; Vassar R
    Mol Neurodegener; 2015 Jan; 10():1. PubMed ID: 25567526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14,15-Epoxyeicosatrienoic Acid Alleviates Pathology in a Mouse Model of Alzheimer's Disease.
    Chen W; Wang M; Zhu M; Xiong W; Qin X; Zhu X
    J Neurosci; 2020 Oct; 40(42):8188-8203. PubMed ID: 32973044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of early proteomic alterations in 5xFAD Alzheimer's disease neonatal mouse model via MALDI-MSI.
    Uras I; Karayel-Basar M; Sahin B; Baykal AT
    Alzheimers Dement; 2023 Oct; 19(10):4572-4589. PubMed ID: 36934297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abundance of Aβ₅-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease.
    Guzmán EA; Bouter Y; Richard BC; Lannfelt L; Ingelsson M; Paetau A; Verkkoniemi-Ahola A; Wirths O; Bayer TA
    Mol Neurodegener; 2014 Apr; 9():13. PubMed ID: 24694184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinacrine directly dissociates amyloid plaques in the brain of 5XFAD transgenic mouse model of Alzheimer's disease.
    Park S; Kim HY; Oh HA; Shin J; Park IW; Yoon S; Woo DH; Kim Y
    Sci Rep; 2021 Jun; 11(1):12043. PubMed ID: 34103615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer's disease.
    Andersen JV; Skotte NH; Christensen SK; Polli FS; Shabani M; Markussen KH; Haukedal H; Westi EW; Diaz-delCastillo M; Sun RC; Kohlmeier KA; Schousboe A; Gentry MS; Tanila H; Freude KK; Aldana BI; Mann M; Waagepetersen HS
    Cell Death Dis; 2021 Oct; 12(11):954. PubMed ID: 34657143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive Intestinal Peptide Decreases β-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer's Disease.
    Korkmaz OT; Ay H; Aytan N; Carreras I; Kowall NW; Dedeoglu A; Tuncel N
    J Mol Neurosci; 2019 Jul; 68(3):389-396. PubMed ID: 30498985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinal Vascular Physiology Biomarkers in a 5XFAD Mouse Model of Alzheimer's Disease.
    Matei N; Leahy S; Blair NP; Burford J; Rahimi M; Shahidi M
    Cells; 2022 Aug; 11(15):. PubMed ID: 35954257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.